Last reviewed · How we verify
NCT04936373
Quality of Life of Patients With Pregnancy Related VTE
trial in Health, Subjective in 112 participants. Completed in 2 March 2021.
20 January 2021
Quick facts
| Lead sponsor | University of Jordan |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 112 |
| Start date | 1 October 2020 |
| Primary completion | 20 January 2021 |
| Estimated completion | 2 March 2021 |
| Sites | 2 locations across Jordan |
Conditions studied
- Health, Subjective — all drugs for Health, Subjective →
Sponsor
University of Jordan
Who can join
Adults 18 to 49, female only, with Health, Subjective. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A retrospective study of the quality of life and problems experienced by patients who developed pregnancy related VTE. It involves patients seen at JUH in 2012-2020. A questionnaire will be filled by those patients and any other patients in Jordan. It was translated to an Arabic form from EQ-5D, VEINES-QOL/SYM questionnaire and PEmb-QoL. The quality of their lives will be assessed and the problems encountered are going to be analyzed to try to find some solutions. This project is going to be a national research project with the efforts to try to find common platforms for those patients and nidus to establish a national support group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Impact of Pregnancy-Related Venous Thromboembolism on Quality of Patients' Lives.
Al-Husban N, Alnsour LN, El-Adwan Z, Saleh NA, et al · · 2021 · cited 2× · PMID 34747226 · DOI 10.1177/10760296211040873
Verify or expand the search:
- PubMed search for NCT04936373
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Health, Subjective
Currently open trials in the same condition.
- NCT07447440 — Role of Pro-Resolving Lipid Mediators in Obesity-Associated Diseases · recruiting
- NCT06829485 — Florida Community-Engaged Research Alliance (FL-CEAL) · NA · recruiting
- NCT06392880 — Comparison of Floss Band Application and Mulligan Mobilization · NA · recruiting
- NCT06575907 — Health, Functioning, Work, and Experiences of Social and Health Services of Persons With Stroke · active not recruiting
- NCT05760001 — The IGNITE for Kids Study on Concentrated Investment in Black Neighborhoods and Child Health and Well-Being · NA · active not recruiting
Other University of Jordan trials
Trials by the same sponsor.
- NCT07370545 — Impact of Presentation Sequence on Patient Tooth Shade Selection · NA · completed
- NCT07279285 — Sweet-Tasting Solution Versus Placebo to Reduce Pain During Local Anesthetic Injection in Children · NA · not yet recruiting
- NCT07310485 — Examining the Impact of Phytoestrogens Supplementation on the Gene Expression, and Premenstrual Syndrome in Primenopausa · NA · enrolling by invitation
- NCT06977009 — Influence of Occlusal Reduction on Endodontic Postoperative Pain · NA · recruiting
- NCT07212413 — Effect of Snow-plow Technique on the Postoperative Pain Following Direct Composite Restoration · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04936373 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Jordan
- Last refreshed: 18 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04936373.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing